In gastric cancer and breast cancer, lower grade of expression of METTL14 is associated with poorer prognosis, while overexpression of METTL14 in certain types of tumors is related to tumor proliferation and metastasis (50, 51). This evidence concerns the gene METTL14 and breast carcinoma.